Company Description
Evogene Ltd., together with its subsidiaries, operates as a computational biology company.
It focuses on product discovery and development in life-science based industries, including human health, agriculture, and other industrial applications through the use of its Computational Predictive Biology (CPB) platform.
The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance.
The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, gastrointestinal inflammatory related disorders, and antimicrobial resistance organisms.
The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses.
The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally.
Evogene Ltd. was incorporated in 1999 and is headquartered in Rehovot, Israel.
| Country | Israel |
| Founded | 1999 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 142 |
| CEO | Ofer Haviv |
Contact Details
Address: 13 Gad Feinstein Street, Park Rehovot Rehovot, 7638517 Israel | |
| Phone | 972 8 931 1900 |
| Website | evogene.com |
Stock Details
| Ticker Symbol | EVGN |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001574565 |
| CUSIP Number | M4119S104 |
| ISIN Number | IL0011050551 |
| SIC Code | 2870 |
Key Executives
| Name | Position |
|---|---|
| Dr. Dan Jacob Gelvan Ph.D. | Chief Executive Officer of Ag Plenus Ltd. |
| Yoash Zohar | Chief Executive Officer of Casterra Ag Ltd. |
| Amit Noam Capt. res. | Chief Executive Officer of Lavie Bio Ltd. |
| Dr. Elran Hillel Haber M.B.A., Ph.D. | Chief Executive Officer of Biomica Ltd |
| Dr. Brian Ember | Chief Executive Officer of AgPlenus Ltd |
| Ofer Haviv CPA | Chief Executive Officer, President and Director |
| Yaron Eldad | Chief Financial Officer |
| Liat Foigel Wejgman | Vice President of Human Resources |
| Russ Putland | Vice President of Commercial of Lavie Bio Ltd. |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 28, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Mar 28, 2025 | POS AM | Post-Effective amendments for registration statement |
| Mar 27, 2025 | 20-F | Annual and transition report of foreign private issuers |
| Mar 6, 2025 | 424B3 | Prospectus |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Mar 6, 2025 | 6-K | Report of foreign issuer |
| Feb 12, 2025 | 424B3 | Prospectus |
| Feb 12, 2025 | 6-K | Report of foreign issuer |
| Feb 5, 2025 | 6-K | Report of foreign issuer |
| Jan 15, 2025 | 6-K | Report of foreign issuer |